Cumberland Pharmaceu (CPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 34,388 | 29,345 | 41,150 | 33,026 | 33,519 |
| Cost of Goods | 7,421 | 6,017 | 7,371 | 5,959 | 4,968 |
| Gross Profit | 26,967 | 23,328 | 33,780 | 27,067 | 28,551 |
| Operating Expenses | 36,677 | 34,518 | 38,232 | 29,459 | 28,407 |
| Operating Income | -9,288 | -11,173 | -4,081 | -1,433 | 1,112 |
| Interest Expense | 246 | 196 | 93 | 106 | 74 |
| Other Income | 243 | 564 | 299 | 205 | 209 |
| Pre-tax Income | -9,291 | -10,804 | -3,875 | -1,335 | 1,247 |
| Income Tax | -79 | 17 | 4,175 | -331 | 576 |
| Net Income Continuous | -9,212 | -10,821 | -8,050 | -1,004 | 671 |
| Net Income Discontinuous | 5,665 | 3,782 | N/A | N/A | N/A |
| Minority Interests | -9 | -76 | -71 | -59 | -60 |
| Net Income | $-3,538 | $-6,963 | $-7,979 | $-945 | $731 |
| EPS Basic Total Ops | -0.23 | -0.45 | -0.50 | -0.06 | 0.04 |
| EPS Basic Continuous Ops | -0.60 | -0.69 | -0.51 | -0.06 | 0.04 |
| EPS Basic Discontinuous Ops | 0.37 | 0.24 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.23 | -0.45 | -0.50 | -0.06 | 0.04 |
| EPS Diluted Continuous Ops | -0.60 | -0.69 | -0.51 | -0.06 | 0.04 |
| EPS Diluted Discontinuous Ops | 0.37 | 0.24 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,884 | $-8,190 | $-1,434 | $964 | $3,358 |